
In a subset of patients that had experienced a previous stroke or transient ischemic attack (TIA), treatment with the investigational drug apixaban resulted in a reduced rate of stroke and systemic embolism compared with warfarin, according to a recent subset analysis of a major clinical trial. Stroke is the third-leading…
Read more »
Study finds high risk of recurrence in Indian patients with transient ischemic attack and minor ischemic stroke
A recent study in India tracked the short-term risk of additional events in patients who experienced transient ischemic attacks (TIAs) and minor ischemic strokes (MISs). TIAs and MISs, cerebrovascular events that are not acute, are associated with a risk of recurrence or deterioration. “This is the first Indian data on…
Read more »